rs8047300

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016373.4(WWOX):​c.1057-188556C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.739 in 149,200 control chromosomes in the GnomAD database, including 40,242 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.74 ( 40242 hom., cov: 30)

Consequence

WWOX
NM_016373.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.12

Publications

3 publications found
Variant links:
Genes affected
WWOX (HGNC:12799): (WW domain containing oxidoreductase) This gene encodes a member of the short-chain dehydrogenases/reductases (SDR) protein family. This gene spans the FRA16D common chromosomal fragile site and appears to function as a tumor suppressor gene. Expression of the encoded protein is able to induce apoptosis, while defects in this gene are associated with multiple types of cancer. Disruption of this gene is also associated with autosomal recessive spinocerebellar ataxia 12. Disruption of a similar gene in mouse results in impaired steroidogenesis, additionally suggesting a metabolic function for the protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
WWOX Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive spinocerebellar ataxia 12
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
  • developmental and epileptic encephalopathy, 28
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • 46,XY partial gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.833 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016373.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WWOX
NM_016373.4
MANE Select
c.1057-188556C>A
intron
N/ANP_057457.1Q9NZC7-1
WWOX
NM_001291997.2
c.718-188556C>A
intron
N/ANP_001278926.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WWOX
ENST00000566780.6
TSL:1 MANE Select
c.1057-188556C>A
intron
N/AENSP00000457230.1Q9NZC7-1
WWOX
ENST00000402655.6
TSL:1
c.410-188556C>A
intron
N/AENSP00000384238.2Q9NZC7-6
WWOX
ENST00000406884.6
TSL:1
c.517-188556C>A
intron
N/AENSP00000384495.2Q9NZC7-5

Frequencies

GnomAD3 genomes
AF:
0.739
AC:
110116
AN:
149100
Hom.:
40214
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.780
Gnomad AMI
AF:
0.640
Gnomad AMR
AF:
0.756
Gnomad ASJ
AF:
0.683
Gnomad EAS
AF:
0.854
Gnomad SAS
AF:
0.676
Gnomad FIN
AF:
0.659
Gnomad MID
AF:
0.665
Gnomad NFE
AF:
0.723
Gnomad OTH
AF:
0.741
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.739
AC:
110191
AN:
149200
Hom.:
40242
Cov.:
30
AF XY:
0.733
AC XY:
53496
AN XY:
72934
show subpopulations
African (AFR)
AF:
0.780
AC:
30862
AN:
39584
American (AMR)
AF:
0.756
AC:
11386
AN:
15070
Ashkenazi Jewish (ASJ)
AF:
0.683
AC:
2358
AN:
3454
East Asian (EAS)
AF:
0.854
AC:
4380
AN:
5130
South Asian (SAS)
AF:
0.675
AC:
3223
AN:
4774
European-Finnish (FIN)
AF:
0.659
AC:
6815
AN:
10348
Middle Eastern (MID)
AF:
0.667
AC:
192
AN:
288
European-Non Finnish (NFE)
AF:
0.723
AC:
48841
AN:
67558
Other (OTH)
AF:
0.745
AC:
1552
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1438
2875
4313
5750
7188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
838
1676
2514
3352
4190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.717
Hom.:
42417
Bravo
AF:
0.742

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.086
DANN
Benign
0.31
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8047300; hg19: chr16-79056949; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.